Shift verification effort from a single, time-consuming flat run to a more efficient, distributed, and scalable process.
The merger feasibility study to be done on a potential merger between Clymer, Sherman and Panama schools has taken another ...
Stockhead on MSN
Alterity delivers encouraging phase II data in MSA trial
Alterity Therapeutics’ phase II study of its lead compound ATH434 in multiple system atrophy (MSA) has been featured in an ...
Exploratory Phase 2 analysis shows Verrica’s novel oncolytic peptide, VP-315, reprograms the tumor microenvironment, ...
Investigator-initiated study shows potential for EchoSolv AS to drive improved patient outcomes when used to support cardiologist in identifying severe AS particularly in womenNEDA study of 1.2M ...
Now, in a presentation discussing the subject of remakes and remasters further, Ampere Analysis senior analyst Katie Holt has ...
Servier today announced that it will present new and updated data at the 67th Annual Meeting of the American Society of Hematology (ASH), December 6-9, 2025, in Orlando, Florida. Presentations will ...
LinkDaddy has announced its Backlink Strategy Report technology, featuring dual AI engines. The system integrates data from ...
The trial was halted due to inadequate efficacy, Jay Bradner, M.D., Amgen’s executive vice president of R&D, said during a Nov. 4 call with investors, after an ad hoc analysis requested by an internal ...
Nouscom Presents New Positive Phase 1/2b data of NOUS-209 at SITC 2025, Supporting Plans to Initiate Registration-Enabling ...
Accurate, reliable results play a role in free and fair elections. So does explaining the data and helping people understand ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results